MEDDICC
43.8
3.5 of 8 points
All deals/Larkspur Biotech
Mid-Market · Solution Review · close Oct 12 2026
Theo Brooks · opp-larkspur
$205,000
MEDDICC
43.8
3.5 of 8 points
Days since last meaningful call
2 days
call-larkspur-2
External voices
1
Economic buyer on a call: no
Passed — category stands.
Larkspur Biotech stays in Best Case. The evidence gate does not promote deals; it only demotes unsupported Commit and Best Case calls.
Last meaningful external call was 2 days ago. Commit requires a meaningful external call within 14 days. 0 short call(s) were ignored.
Dr. Helen Cho is named in the CRM economic-buyer field and does not appear as a participant on any call.
Score 43.8 / 100 from 3.5 of 8 points. 2 field(s) corroborated on a call (1.0 each), 3 CRM-only (0.5 each), 3 absent (0).
1 distinct external participant(s) (seniority-weighted score 1.5): Omar Diaz.
Call evidence counts 1.0, CRM-only 0.5, absent 0.
43.8 / 100
Medical-info line compliance coverage
0.5 pt
Dr. Helen Cho, VP Medical Affairs
0.5 pt
21 CFR Part 11, audit trail
0.5 pt
No value recorded.
0 pt
No value recorded.
0 pt
MI calls sampled at 3%
1 pt
Omar Diaz, Manager, MI
1 pt
No value recorded.
0 pt
Calls under 3 minutes are not meaningful for freshness.
Larkspur MI-line intro
Aug 20 2026 · 26 min · call-larkspur-1
Meaningful · External: Omar Diaz (manager)
Omar said medical-info calls are sampled at 3%. Dr. Helen Cho was named as economic buyer and did not join.
Part 11 questions
Sep 1 2026 · 14 min · call-larkspur-2
Meaningful · External: Omar Diaz (manager)
Omar asked about 21 CFR Part 11 audit trail. Still no medical-affairs buyer on the record.